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Abstract Delayed engagement in HIV care threatens the
success of HIV treatment programs in sub-Saharan Africa
and may be influenced by depression. We examined the
relationship between depression prior to HIV diagnosis and
engagement in HIV care at a primary care clinic in
Johannesburg, South Africa. We screened 1683 patients for
depression prior to HIV testing using the Patient Health
Questionnaire-9. Among patients who tested positive for
HIV we assessed linkage to HIV care, defined as obtaining
a CD4 count within 3 months. Among those who linked to
care and were eligible for ART, we assessed ART initiation
within 3 months. Multivariable Poisson regression with a
robust variance estimator was used to assess the association
between depression and linkage to care or ART initiation.
The prevalence of HIV was 26 % (n = 340). Among HIV-
infected participants, the prevalence of depression was
30 %. The proportion of linkage to care was 80 % among
depressed patients and 73 % among patients who were not
depressed (risk ratio 1.08; 95 % confidence interval 0.96,
1.23). Of the participants who linked to care, 81 % initiated
ART within 3 months in both depressed and not depressed
groups (risk ratio 0.99; 95 % confidence interval 0.86,
1.15). Depression was not associated with engagement in
HIV care in this South African primary care setting. Our
unexpected findings suggest that some depressed HIV-in-
fected patients might be more likely to engage in care than
their counterparts without depression, and highlight the
complex relationship between depression and HIV infec-
tion. These findings have led us to propose a new frame-
work relating HIV infection, depression, and the population
under study.
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Introduction
In sub-Saharan Africa, the prevalence of depression among
HIV-infected people is reported to be 30–60 %, several
times greater than prevalence in the general population
[1–9]. The relationship between depression and HIV
infection is complex, as depression can be a risk factor for
HIV acquisition as well as a consequence of HIV infection
[10, 11]. Depression also has been recognized as a pre-
dictor of poor outcomes among people with HIV infection,
including faster disease progression and a greater risk of
HIV-associated morbidity and mortality [12–14].
Delayed linkage or poor retention in HIV care has
emerged as a major operational challenge to HIV treatment
programs and may be affected by poor mental health
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[15–19]. Among people enrolled in HIV care, depression
appears to negatively affect health care utilization behav-
iors, leading to delayed initiation of antiretroviral treatment
(ART), missed clinic visits, and reduced adherence to ART
[11, 12, 20–24]. Although the effect of depression on ART
adherence is well documented, the impact of depression on
linkage to care has been less clearly delineated [25–27].
We conducted an observational study to examine the
relationship between underlying depression detected
immediately prior to HIV diagnosis and engagement in
HIV care among a cohort of 340 persons presenting for
primary care an urban clinic in Johannesburg, South
Africa. We hypothesized that HIV-infected patients with
depressive symptoms preceding HIV diagnosis would be
less likely to engage in care compared to their counterparts
without depression. Among those who did link to care, we
hypothesized that depressed patients who were eligible for
ART would be less likely to initiate ART than those who
were not depressed. Finally, we designed a conceptual
framework to contextualize the complex association
between depression and engagement in care among HIV-
infected people—this framework is presented in the dis-
cussion section of this manuscript.
Methods
Study Setting and Population
Witkoppen Health and Welfare Centre (WHWC) is a high-
volume primary health care clinic in northern Johannes-
burg, South Africa that provides comprehensive services
predominantly to persons living in densely populated peri-
urban formal and informal settlements. At WHWC, every
clinic client with an unknown HIV status or with a negative
HIV test more than 3 months old routinely undergoes opt-
out HIV counseling and testing (HCT).
The study population comprised a randomly selected
subset of patients who were undergoing routine HCT at
WHWC between September 2012 and April 2013. Partic-
ipants were eligible for enrollment if they presented at
WHWC for any reason, had unknown HIV status, tested
positive for HIV at the study visit, were at least 18 years
old, not pregnant by self-report, could communicate in one
of 5 common languages used by interviewers (English,
isiZulu, isiXhosa, seSotho, seTswana), and were able to
provide informed consent. Persons found to be experienc-
ing acute suicidal ideation were excluded and referred for
immediate assistance. The Institutional Review Board at
the University of North Carolina (12-1730) and the Human
Research Ethics Committee at the University of Witwa-
tersrand (M120725) approved this study.
Study Procedures
Eligible patients were selected randomly for recruitment
each day, prior to undergoing HCT. After providing
informed consent, the patient was interviewed by a trained
lay-interviewer. Due to low literacy in the study popula-
tion, an interviewer-administered study questionnaire was
used and responses were recorded on a paper form.
Depression was measured using the Patient Health
Questionnaire-9 (PHQ-9), a 9-item depression screening
tool that determines the presence and frequency of the 9
core depressive symptoms identified in the DSM-IV over
the previous 2 weeks [28]. A 4-point Likert scale is used to
rate the severity of each item by asking respondents how
often they have experienced the symptom over the past
2 weeks (0 = not at all, 1 = several days, 2 = more than
half the days, 3 = nearly every day). The total PHQ-9
score is determined by summing the scores for each item.
Scores range from 0-27, with a score of 10 or higher typ-
ically used to indicate the presence of a depressive disorder
that would benefit from treatment. This tool has been
widely utilized in Western settings and in sub-Saharan
Africa [29–33]. Additionally, the PHQ-9 was recently
validated against the Mini Neuropsychiatric Interview
among patients in our study population, and found to have
a sensitivity of 78.7 % (95 % CI 64.3–89.3) and specificity
of 83.4 % (95 % CI 79.1–87.2) when using the standard
cutoff score of C10 [34]. The PHQ-9 was administered
prior to HIV testing to avoid any potential impact of the
HIV test result on the PHQ-9 answers. The study ques-
tionnaire included questions about substance abuse and
knowledge of HIV status from prior testing experiences.
Questions regarding knowledge of HIV status were added
to the study questionnaire after 2 months of data collection,
so a small number of participants did not answer these
questions; absence of this information should be unrelated
to other variables, in particular to depression status and
linkage to care.
After completing the questionnaire, patients were tested
for HIV with rapid HIV tests. Patients who tested positive
by two rapid dried blood spot tests were registered at the
HIV clinic and blood was drawn for CD4 testing that day.
HIV infected patients were counseled regarding their
results and given an appointment to return for collection of
CD4 results and HIV staging, typically within 2 weeks, but
up to 4 weeks from the diagnosis date.
Socio-demographic information and clinical information
from the date of HIV testing was obtained from Thera-
pyEdge, the HIV electronic clinic record database. Elec-
tronic clinic records were reviewed at least 6 months after
study enrollment to assess clinic visits and ART status.
Study data were collected and managed using Research
revealed that they knew their positive status during pre-test
counseling, left the clinic prior to testing, were referred for
urgent mental health care due to their responses on the
depression screen, or were missing for unknown reasons.
Patients who did not test for HIV were excluded from this
analysis. Of the 1384 who did test for HIV, 60 were sub-
sequently excluded because they already knew they were
HIV positive according to their responses to our study
questionnaire. Participants enrolled during the first
2 months of the study were not asked about knowledge of
their HIV status. Based on the proportion of the population
reporting prior knowledge of HIV infection, we estimate
that an additional 6 or 7 persons may have known their
positive HIV status.
Of the final 1324 participants, 26 % (n = 340) were
HIV-infected. Nearly a quarter of the 1324 participants
(22 %) were depressed. Depression was much more com-
mon among patients who subsequently tested HIV positive
compared to those who tested HIV negative (30.3 vs
19.7 %, V2 = 16.6, p\ 0.0001). All 340 patients with
newly diagnosed HIV infection were included and consti-
tute the study population for the remaining analyses.
Participants with newly diagnosed HIV infection had
a median age of 35 years (IQR 30–40 years) and just
over half were women (54 %). About half of the par-
ticipants were from South Africa (46 %) while most
others were from Zimbabwe (42 %). A third reported
drinking any alcohol (32 %) and 59 % were employed.
Nearly half (47 %) of the participants self-reported only
fair or poor health status. The median baseline CD4
count at HIV diagnosis was 188 cells/mm3 (IQR 86–345
cells/mm3); three-quarters of the patients who had a
reported CD4 count were eligible for ART at the time of
diagnosis.
Among the 340 participants, 30 % were considered
depressed based on PHQ-9 criteria. Depressed patients
were slightly older (37 vs 35 years, t-statistic = -2.4,
p = 0.019). Those who were depressed were also more
likely to self-report fair or poor health rather than excellent,
very good, or good health (V2 = 9.3, p = 0.002).
Depressed patients with newly diagnosed HIV infection
had a lower mean CD4 count on the date of HIV diagnosis
compared to patients who were not depressed (201 vs 264,
t-statistic = 2.4, p = 0.018) (Table 1).
Overall, three-quarters (75 %) of participants linked to
care to obtain a CD4 count within 3 months of diagnosis.
About 60 % of the patients under age 30 linked to care,
compared to 78 % of those age 30–39, 89 % of those age
40–49, and 68 % of those who were 50 or older. Those who
linked to care were more likely to report fair or poor health
status (V2 = 5.0, p = 0.026) and have lower mean CD4
counts (232 vs 295, t-statistic = 2.0, p = 0.042) compared
to patients who did not link to care (Table 2).
Electronic Data Capture (REDCap) tools hosted at the 
University of North Carolina, Chapel Hill [35].
Sample Size
The sample size we aimed to enroll for this study was at 
least 300 HIV-infected patients in order to have 80 %
power to detect a 15 % difference in linkage to care 
between patients who were depressed versus those who 
were not depressed. Based on previous estimates in the 
region we assumed: (1) a 35 % prevalence of depression 
among HIV-infected individuals, and (2) that 75 % of the 
population of HIV-infected patients would link to care 
[19]. We hypothesized that 60 % or less of those patients 
who were depressed would link to care.
Statistical Analysis
The primary outcome was linkage to care, defined as 
returning to WHWC for CD4 staging within 3 months of 
the diagnosis visit [19]. A secondary outcome among those
who were eligible for ART (CD4 \ 350) was initiation of 
ART within 3 months of the staging visit. The main factor 
of interest in these analyses was probable major depression, 
defined as a PHQ-9 score of 10 or higher. Higher PHQ-9 
cutoff scores of 12 and 15 were also considered, with no 
change in results. Additional variables included in multi-
variable analyses include age, gender, employment status, 
country of birth, alcohol use, perceived health status, and 
baseline CD4 count. Age was categorized and modeled 
using indicator variables, with the youngest age group 
(\30 years) as the referent.
Baseline patient characteristics were summarized using 
frequencies and proportions for categorical variables and 
medians and interquartile ranges (IQR) for continuous 
variables. Poisson regression with a robust variance esti-
mator was used to estimate risk ratios (RRs), adjusted risk 
ratios (aRRs), and 95 % confidence intervals (CIs). For the 
linkage to care outcome we assessed for but found no 
evidence of interaction between CD4 count and depression, 
and perceived health status and depression; these results 
are not reported further. Stata version 13 (StataCorp, Col-
lege Station, TX, USA) was used for all analyses.
Results
Between September 2012 and April 2013, 1683 people 
provided informed consent to participate in this study. 
Nearly all (n = 1681) completed depression screening and 
82 % (n = 1386) subsequently tested for HIV. Those who 
were not tested either refused HIV testing, were still in the 
window period from an HIV test less than 3 months old,
The proportion of patients who linked to care within
3 months was 80 % in the depressed group and 73 % in the
group that was not depressed (unadjusted RR 1.08, 95 %
CI 0.96, 1.23). In a multivariable model adjusting for
potential confounding variables, depression was not asso-
ciated with linkage to care (adjusted RR 1.05, 95 % CI
0.93, 1.1) (Table 3).
Among the 185 patients who linked to care, 8
reported transferring care to another clinic and 1 passed
away within the 3 months after HIV diagnoses. Of the
remaining 176, 81 % (n = 143) initiated ART within
3 months of obtaining a CD4 count. This corresponds
to about two-thirds (63 %) of the study population
eligible to initiate ART at the time of enrollment ini-
tiating treatment within the 6 months after HIV
diagnosis. The percentage of depressed and not
depressed patients who linked to care and initiated ART
within 3 months was 81 % in both groups (unadjusted
RR 0.99, 95 % CI 0.86, 1.15). In a multivariable model
adjusted for all potential confounders, we found no
association between depression and ART initiation (RR
1.01, 95 % CI 0.87, 1.17).
Discussion
In this population of HIV-infected people at a primary care
clinic in Johannesburg, South Africa, the prevalence of
depressive symptoms at the time of HIV testing was high,
with 30 % of patients experiencing probable depression.
Table 1 Characteristics of the
study population by depression
Characteristic Total study population Depressive symptoms n (%)
(n = 340) PHQ-9\ 10 (n = 237) PHQ-9 C 10 (n = 103)
Age
\30 85 (25.0) 61 (25.7) 24 (23.3)
30–39 163 (47.9) 123 (51.9) 40 (38.8)
40–49 64 (18.8) 38 (16.03) 26 (25.2)
C50 28 (8.2) 15 (6.33) 13 (12.6)
Gender
Male 155 (45.6) 110 (46.4) 58 (56.3)
Female 185 (54.4) 127 (53.6) 45 (43.7)
Employment status, n (%)
Employed 201 (62.6) 145 (64.4) 56 (58.3)
Unemployed 120 (37.4) 80 (35.6) 40 (41.7)
Country of birth, n (%)
South Africa 156 (45.9) 107 (45.2) 49 (47.6)
Other country 184 (54.1) 130 (54.9) 54 (52.4)
Alcohol use, n (%)
Any 109 (32.3) 76 (32.1) 33 (32.7)
None 229 (67.7) 161 (67.9) 68 (67.3)
Perceived health status, n (%)
Excellent 29 (8.6) 26 (11.0) 3 (3.0)
Very good 36 (10.7) 28 (11.8) 8 (7.9)
Good 115 (34.0) 85 (35.9) 30 (29.7)
Fair 66 (19.5) 50 (21.1) 16 (15.8)
Poor 92 (27.2) 48 (20.3) 44 (43.6)
CD4 count, n (%)
\100 86 (28.6) 56 (27.3) 30 (31.3)
100–199 73 (24.3) 42 (20.5) 31 (32.3)
200–349 67 (22.3) 51 (24.9) 16 (16.7)
C350 75 (24.9) 56 (27.3) 19 (19.8)
# of clinic visits in first 3 months
HIV diagnosis visit 83 (24.4) 62 (26.2) 21 (20.4)
1 53 (15.6) 38 (16.0) 15 (14.6)
C2 204 (60.0) 137 (57.8) 67 (65.0)
Table 2 Population
characteristics according to
linkage to care or ART initiation
Characteristic Linkage to care (N = 340) ART initiation (N = 176)
n % Linked to care p valuea n % Initiating ART p valuea
Age in years
\30 85 62 0.001 29 83 0.960
30–39 163 78 93 81
40–49 64 89 41 83
C50 28 68 13 77
Gender
Male 155 75 0.941 87 77 0.154
Female 185 75 89 85
Employment status
Employed 201 77 0.409 107 81 0.966
Unemployed 120 73 58 81
Country of birth
South Africa 156 75 0.908 76 82 0.922
Other country 184 76 100 81
Alcohol use
None 229 76 0.546 119 83 0.312
Any 109 73 56 77
Perceived health status
Excellent/very good/good 180 71 0.026 79 85 0.261
Fair or poor 158 81 96 78
CD4 count
\100 86 85 0.396 68 78 0.569
100–199 73 78 55 85
200–349 67 82 53 81
C350 75 75 – –
Probable depression
Depressed (PHQ C 10) 103 80 0.224 63 81 0.940
Not depressed (PHQ\ 10) 237 73 113 81
a Tests based on Pearson’s Chi-square for categorical variables
Table 3 Risk ratios for linkage
to care or ART initiation for
patients with depressive
symptoms compared to patients
without depressive symptoms
Linkage to care
Model n Risk ratio 95 % CI
Unadjusted
Depressed (PHQ C 10) vs not depressed (PHQ\ 10) 340 1.08 (0.96, 1.23)
Adjusteda
Depressed (PHQ C 10) vs not depressed (PHQ\ 10) 280 1.05 (0.93, 1.18)
ART initiation
Model n Risk ratio 95 % CI
Unadjusted
Depressed (PHQ C 10) vs not depressed (PHQ\ 10) 176 0.99 (0.86, 1.15)
Adjusteda
Depressed (PHQ C 10) vs not depressed (PHQ\ 10) 164 1.01 (0.87, 1.17)
a Adjusted for age, gender, employment, country of birth, alcohol, perceived health, CD4
We found that underlying depression did not influence
subsequent linkage to HIV care or initiation of ART. To
our knowledge, this study is the first to assess depression in
a primary care population undergoing HIV testing, and is
only the second to assess depression before HIV testing
results were known.
The primary care context is particularly important for
optimizing engagement in HIV care as a large proportion of
HIV testing and treatment in sub-SaharanAfrica takes place in
these settings.Overallwe found significant rates of loss to care
afterHIV testing andCD4count testing amongbothdepressed
and not depressed patients. We observed that depressed
patients who actively seek out health care may link to HIV
care and initiate ART at rates higher than or comparable to
people without depression, although this study did not have
enough power to find a statistically significant difference
between the two groups. While this population might initially
link to HIV care and initiate ART effectively, further work
will be required to explore ART adherence, retention in care,
and durability of depression among these patients.
Our study adds to a limited knowledge base relating
mental illness and engagement in care among HIV-infected
people. In Uganda, severe mental illness was associated
with worse retention in care among patients initiating ART
[26]. In Durban, South Africa, depressive symptoms were
very common (prevalence = 55 %) among patients pre-
senting for HIV testing who were also screened for
depression [27]. In the Durban population, patients with
depressive symptoms were less likely than those without
depressive symptoms to link to HIV care, as we had
hypothesized in the current study. However, the relation-
ship between depression and linkage to HIV care differed
according to referral method. Depressed patients referred
for HIV testing by a provider showed decreased linkage to
care compared to provider-referred patients who were not
depressed. In contrast, depressed patients who self-referred
for HIV testing showed increased linkage to care compared
to self-referred patients who were not depressed.
Similar to the study in Durban, we screened for
depression prior to the time of HIV diagnosis. However, we
targeted patients undergoing routine HIV testing during the
course of a primary care visit. Although underlying
depressive symptoms were more common in people who
tested positive for HIV compared to those who tested
negative (30 vs 20 %), we did not find a difference in
returning to the clinic to obtain a CD4 count or initiating
ART. As this study was powered to detect a larger differ-
ence in linkage to care than was seen, the null effect may in
part be due to limited sample size. However, though are
results are not statistically significant they suggest that
depressed patients with HIV may link to care at higher or at
least similar rates compared to patients who are not
depressed, contrary to our original hypothesis. In primary
care settings, patients who are high utilizers of medical
care commonly have a higher prevalence of depression,
and seek care for minor illnesses at a greater rate than
patients without mental illness [36, 37]. Because our study
population comprised patients who presented to a primary
care facility, one explanation for our unexpected findings is
that we may have selected for high utilizers who have high
rates of depression but are less likely to be lost to HIV care.
Our clinic-based study would not capture depressed HIV-
infected people who are particularly unmotivated to seek
care (‘‘low-utilizers’’). These interpretations must be taken
in light of our sample size limitations discussed above, and
future studies will need to be carefully designed to test the
new hypotheses suggested by this work.
The variation in results between our study and the
Durban study highlights the complexities inherent in
studying depression and engagement in HIV care.
Depression is both a cause and an effect of HIV infection,
and consequently, depression either pre- or post-HIV
diagnosis might influence engagement in HIV care. The
relationship between HIV diagnosis, depression status, and
depression screening is complex, necessitating clear
delineation of distinct study populations that should be
considered separately. To address this issue and put the
current study into context, we have formulated a frame-
work to describe these populations relative to the HIV
engagement in care continuum (Fig. 1) [38, 39].
The first population (Population 0) in this framework
includes all depressed HIV-infected patients in a commu-
nity, prior to HIV diagnosis. A proportion of Population 0
seeks medical care, yielding the next group (Population 1).
Population 1 comprises patients presenting for care, who
are not yet diagnosed with HIV. This population includes
two sub-groups who have differing motivations for seeking
health care—(a) patients presenting for primary care who
undergo routine HIV testing, and (b) patients who are
either self-referred or provider-referred, and present
specifically for HIV testing. In Population 1, we can study
the effect of being depressed immediately prior to HIV
diagnosis on engagement in HIV care. This population was
assessed in the current study. Population 2 includes people
with HIV infection after diagnosis. Subgroups in this
population vary with the timing of depression screening:
(a) immediately after diagnosis (subgroup a), (b) during the
pre-ART period, (c) at ART initiation, or (d) after a patient
is maintained in continuous HIV care. People can also
move in and out of the depressed group over time, neces-
sitating regular depression screening to accurately repre-
sent the prevalence of depression. Some people might
move from Population 1 into Population 2 as they move
through the continuum, but others may remain in only one
group. Both Populations 1 and 2 are typically clinic-based
research populations.
social support in the home may also play more significant
roles in daily ART adherence than linkage to care.
This study emphasizes the difficulty of studying the
bidirectional relationship between depression and engage-
ment in HIV care. The complexities of this relationship
necessitate careful consideration of the differences in pop-
ulation, clinic setting, and context to ensure appropriate
interpretation and generalization of results. The impact of
depression prior to HIV diagnosis such as measured in our
cohort may be substantially different than the impact of
depression after HIV diagnosis. We recommend that these
two populations be clearly delineated and explored longi-
tudinally along the engagement in HIV care continuum. To
facilitate this work, we have provided a population frame-
work that can guide future research designed to address this
important association. Further study of the impact of
depression on HIV outcomes is paramount: a third of our
HIV-infected population presented with underlying
depressive symptoms, a quarter of the population did not
link to care, and of those who were eligible for ART, a third
did not initiate treatment. The HIV-care outcomes of this
substantial population will only be improved with carefully
designed interventions.
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